Mycobacterium avium Complex Infection
- 1 February 1997
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 32 (2) , 132-144
- https://doi.org/10.2165/00003088-199732020-00004
Abstract
Mycobacterium aviumcomplex (MAC) is an infrequent pulmonary pathogen in immunocompetent hosts. In patients with AIDS, MAC causes disseminated infection (DMAC) in up to 50% of those with CD4+ counts...Keywords
This publication has 48 references indexed in Scilit:
- Clinical Pharmacokinetics of RifabutinClinical Pharmacokinetics, 1995
- RifabutinDrugs, 1994
- Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndromeThe Journal of Pediatrics, 1994
- Treatment of Disseminated Disease Due to the Mycobacterium avium Complex in Patients with AIDSClinical Infectious Diseases, 1994
- Lack of Acidification in Mycobacterium Phagosomes Produced by Exclusion of the Vesicular Proton-ATPaseScience, 1994
- Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex Disease in Patients Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1993
- Clarithromycin Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- ClarithromycinDrugs, 1993
- Pulse Dosing Versus Continuous Infusion of AntibioticsClinical Pharmacokinetics, 1988
- Adverse Effects of Antituberculosis DrugsDrugs, 1982